Q: What need is Tymora Analytical Operations addressing? A: Virtually all of the current liquid biopsy assays are based on genomic information. But the active molecules in the body that are doing the work and undergoing changes during disease progression are actually proteins....
Q: The Nobel Price in Medicine was awarded recently to James Allison and Tasuku for their work on unleashing the body’s immune system to attack cancer, a breakthrough that has led to an entirely new class of drugs and brought lasting remissions to many patients...
Q: NGS is enhancing patient care through improved diagnostic sensitivity and more precise therapeutic targeting. Prominent examples include cystic fibrosis and cancer. What other clinical areas NGS will most likely to change the standard-of-care in the near future? A: NGS has most drastically impacted the standard...
Q: Patient healthcare data aggregation and analysis is seen as both the panacea for tremendous breakthroughs in precision medicine and as one of its biggest challenges. Are both true and how so? A: The promises and challenges around personal health data aggregation are two sides of...
Q: What research are you or your lab focusing on and why, and what problem(s) are you trying to solve? A: Our overall driving goal is to improve human health, and we do this largely through the development of new tools to study basic biology and...
Q: What need is Travera addressing? A: The cancer community is suffering from a lack of biomarkers that match drugs to patients. The NCI-MATCH study reported in 2016 that fewer than 10% of cancer patients could be matched to a therapy....
Q: Artificial intelligence (AI) techniques have sent vast waves across healthcare, even fueling an active discussion of whether AI doctors will eventually replace human physicians in the future. Do you believe that human physicians will be replaced by machines in the foreseeable future? What are...
Q: The track theme is on the topic “How do we accelerate and deliver on the promise of cancer immunotherapy?” What are some key promises regarding immune-oncology, that we can build upon and translate into reality and how can we expedite delivery? A: The use of...
Q: You are the CEO of Genetic Alliance. What is your role as the CEO and why is this organization so important? A: I actually try to avoid formal roles as CEO; instead, I practice showing up fully for our community: our staff and all of...
Q: Israel is known as a leader in hi-tech innovation. Can you tell us about some of the breakthrough companies in digital health and precision medicine? A: The Israeli life sciences industry continues to grow and improve its global position. Israeli entrepreneurs' ability to take advantage...
